Weidinger, S., Pink, A., Francisco, J., Kurbasic, A., Olsen, C., Vilsbøll, A. and de Bruin Weller, M. (2020) “Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients with Moderate-To-Severe Atopic Dermatitis”, SKIN The Journal of Cutaneous Medicine, 4(6), p. s100. doi: 10.25251/skin.4.supp.100.